Emma J. West

1.1k total citations
22 papers, 360 citations indexed

About

Emma J. West is a scholar working on Genetics, Oncology and Biotechnology. According to data from OpenAlex, Emma J. West has authored 22 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 10 papers in Oncology and 8 papers in Biotechnology. Recurrent topics in Emma J. West's work include Virus-based gene therapy research (14 papers), Cancer Research and Treatments (8 papers) and CAR-T cell therapy research (8 papers). Emma J. West is often cited by papers focused on Virus-based gene therapy research (14 papers), Cancer Research and Treatments (8 papers) and CAR-T cell therapy research (8 papers). Emma J. West collaborates with scholars based in United Kingdom, United States and France. Emma J. West's co-authors include Alan Melcher, Karen J. Scott, Peter J. Selby, Richard G. Vile, Christy Ralph, Alison Merrick, Paul Hatfield, Samantha Turnbull, Elizabeth Appleton and Matt Coffey and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

Emma J. West

22 papers receiving 355 citations

Peers

Emma J. West

GENET

ONCOL

IMMUN

Dongling Gao China

Joachim Hagel United Kingdom

Adel Samson United Kingdom

Masaya Igase Japan

Christianne Groeneveldt Netherlands

FL Graham Canada

Richard J. Aguilar United States

Il-Kyu Choi South Korea

Sarah Knocke Germany

Uxua Mancheño Spain

Dongling Gao China

Emma J. West

232 ×1.2

GENET

257 ×1.4

ONCOL

113 ×0.9

IMMUN

147 ×1.2

33 ×0.8

Citations per year, relative to Emma J. West Emma J. West (= 1×) peers Dongling Gao

Countries citing papers authored by Emma J. West

Since Specialization

Citations

This map shows the geographic impact of Emma J. West's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma J. West with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma J. West more than expected).

Fields of papers citing papers by Emma J. West

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma J. West. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma J. West. The network helps show where Emma J. West may publish in the future.

Co-authorship network of co-authors of Emma J. West

This figure shows the co-authorship network connecting the top 25 collaborators of Emma J. West. A scholar is included among the top collaborators of Emma J. West based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma J. West. Emma J. West is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Samson, Adel, Cristina Smolenschi, Philippe A. Cassier, et al.. (2023). Abstract CT190: Oncolytic virus TG6002 safety and activity after intrahepatic artery administration in patients with liver-dominant metastatic colorectal cancer. Cancer Research. 83(8_Supplement). CT190–CT190. 1 indexed citations

Schuelke, Matthew, Justin H. Gundelach, Matt Coffey, et al.. (2022). Phase I trial of sargramostim/pelareorep therapy in pediatric patients with recurrent or refractory high-grade brain tumors. Neuro-Oncology Advances. 4(1). vdac085–vdac085. 20 indexed citations

West, Emma J., Karen J. Scott, Kaïdre Bendjama, et al.. (2022). Intravenous Oncolytic Vaccinia Virus Therapy Results in a Differential Immune Response between Cancer Patients. Cancers. 14(9). 2181–2181. 8 indexed citations

Short, Susan, Emma J. West, Catherine McBain, et al.. (2022). P11.64.A Long-term follow up and translational data from the ReoGlio phase Ib trial of GM-CSF and intravenous pelareorep (Reovirus) alongside standard of care in GBM. Neuro-Oncology. 24(Supplement_2). ii73–ii73. 2 indexed citations

Migneco, G, Gina B. Scott, Jenny Down, et al.. (2021). Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow niche. Journal for ImmunoTherapy of Cancer. 9(3). e001803–e001803. 14 indexed citations

Anthoney, Alan, Adel Samson, Emma J. West, et al.. (2018). Single intravenous preoperative administration of the oncolytic virus Pexa-Vec to prime anti-tumor immunity.. Journal of Clinical Oncology. 36(15_suppl). 3092–3092. 8 indexed citations

Turnbull, Samantha, Emma J. West, Karen J. Scott, et al.. (2018). Chemotherapy to reverse diminished immune responses (IRs) associated with a raised neutrophil lymphocyte ratio (NLR) in patients with advanced colorectal cancer (aCRC).. Journal of Clinical Oncology. 36(15_suppl). e15635–e15635. 1 indexed citations

Parrish, Christopher, Gina B. Scott, G Migneco, et al.. (2015). Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia. Leukemia. 29(9). 1799–1810. 32 indexed citations

Turnbull, Samantha, Emma J. West, Karen J. Scott, et al.. (2015). Evidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going?. Viruses. 7(12). 6291–6312. 46 indexed citations

10.

Jebar, Adel, Elizabeth J. Ilett, Tim Kottke, et al.. (2015). Abstract A49: Systemic oncolytic reovirus for the treatment of primary and secondary brain tumors. Cancer Immunology Research. 3(10_Supplement). A49–A49. 1 indexed citations

11.

Dave, Rajiv, Adel Jebar, Victoria A. Jennings, et al.. (2014). Viral warfare! Front-line defence and arming the immune system against cancer using oncolytic vaccinia and other viruses. The Surgeon. 12(4). 210–220. 8 indexed citations

12.

Jebar, Adel, Emma J. West, Karen J. Scott, et al.. (2014). P12 * A PHASE I TRIAL OF INTRAVENOUS ONCOLYTIC REOLYSIN(R) IN PATIENTS WITH BRAIN TUMOURS. Neuro-Oncology. 16(suppl 6). vi3–vi3. 2 indexed citations

13.

Jebar, Adel, Emma J. West, Karen J. Scott, et al.. (2014). Oncolytic wild-type reovirus infection in brain tumors following intravenous administration in patients.. Journal of Clinical Oncology. 32(15_suppl). 3104–3104. 3 indexed citations

14.

Ilett, Elizabeth J., Karen J. Scott, Emma J. West, et al.. (2013). Lymphokine‐activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites. International Journal of Cancer. 134(5). 1091–1101. 41 indexed citations

15.

West, Emma J., et al.. (2011). Immune activation by combination human lymphokine-activated killer and dendritic cell therapy. British Journal of Cancer. 105(6). 787–795. 24 indexed citations

16.

Mendonca, Derick A., et al.. (2009). Is There a Relationship Between the Severity of Metopic Synostosis and Speech and Language Impairments?. Journal of Craniofacial Surgery. 20(1). 85–88. 35 indexed citations

17.

Hatfield, Paul, Alison Merrick, Emma J. West, et al.. (2008). Optimization of Dendritic Cell Loading With Tumor Cell Lysates for Cancer Immunotherapy. Journal of Immunotherapy. 31(7). 620–632. 80 indexed citations

18.

Sage, Michaël, Emma J. West, & J.B. Gavin. (1985). Cardiac performance of isolated beating hearts obtained from rats anesthetized by three different agents.. PubMed. 35(2). 153–5. 4 indexed citations

19.

Yachnin, Stanley, Richard A. Larson, & Emma J. West. (1983). Rates of cholesterol biosynthesis are related to early differentiation in acute non‐lymphocytic leukaemia cells. British Journal of Haematology. 54(3). 459–466. 1 indexed citations

20.

Yachnin, Stanley, Richard A. Larson, & Emma J. West. (1983). Rates of cholesterol biosynthesis are related to early differentiation in acute non-lymphocytic leukaemia cells. British Journal of Haematology. 54(3). 459–466. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact